Institutional investors hold a majority ownership of GILD through the 95.67% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.9 Million shares of Gilead Sciences Inc
DEUTSCHE BANK INVESTMENT MANAGEM... Bought 4.1 Million shares of Gilead Sciences Inc
MONTAG & CALDWELL LLC Bought 3.8 Million shares of Gilead Sciences Inc